Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:17 PM
Ignite Modification Date:
2025-12-26 @ 1:17 PM
NCT ID:
NCT00457106
Eligibility Criteria:
Inclusion Criteria:
* Males and females, ages 18-55.
* Ability to sign an informed consent
* Diagnosis of Panic Disorder, or MDD with Panic attacks, single episode, recurrent, or chronic
* HAM-A score \>17
Exclusion Criteria:
* Alcohol or substance abuse within the last 6 months
* Current diagnosis of Obsessive-Compulsive Disorder
* Current diagnosis of Schizophrenia, Schizoaffective Disorder, or Bipolar Mood Disorder
* Use of antipsychotic medications over the two months preceding enrollment in the study
* Changes in antidepressant or mood stabilizer dosing over the two months preceding enrollment in the study
* Previous adverse reaction to risperidone or paroxetine.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00457106
Study Brief:
Protocol Section:
NCT00457106